ALKS Q1 2019 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$223M-0.9% YoY

Gross Profit

$178M79.7% margin

Operating Income

-$76M-34.1% margin

Net Income

-$96M-43.2% margin

EPS (Diluted)

$-0.62

QoQ Revenue Growth

-29.3%

Cash Flow

Operating Cash Flow

$22M

Free Cash Flow

-$1M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$654M

Stockholders' Equity

$1.1B

Cash & Equivalents

$225M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$223M	$225M	-0.9%
Gross Profit	$178M	$181M	-1.6%
Operating Income	-$76M	-$62M	-22.8%
Net Income	-$96M	-$63M	-54.2%

Revenue Segments

Manufactured Product And Royalty

$109M49%

Product

$99M45%

Research And Development

$15M7%